• Home
  • News
  • Calendar
  • About DF/HCC
  • Membership
  • Visitor Center

Aditya Bardia, MD, MPH


  • ReĆ”tegui E, Aceto N, Lim EJ, Sullivan JP, Jensen AE, Zeinali M, Martel JM, Aranyosi AJ, Li W, Castleberry S, Bardia A, Sequist LV, Haber DA, Maheswaran S, Hammond PT, Toner M, Stott SL.
    Tunable nanostructured coating for the capture and selective release of viable circulating tumor cells.
    Adv. Mater. Weinheim. 2015 Mar;27(9):1593-9.
  • Bardia A, Haber DA.
    Solidifying Liquid Biopsies: Can Circulating Tumor Cell Monitoring Guide Treatment Selection in Breast Cancer?.
    J Clin Oncol. 2014 Jul 14.
  • Yu M, Bardia A, Aceto N, Bersani F, Madden MW, Donaldson MC, Desai R, Zhu H, Comaills V, Zheng Z, Wittner BS, Stojanov P, Brachtel E, Sgroi D, Kapur R, Shioda T, Ting DT, Ramaswamy S, Getz G, Iafrate AJ, Benes C, Toner M, Maheswaran S, Haber DA.
    Cancer therapy. Ex vivo culture of circulating breast tumor cells for individualized testing of drug susceptibility.
    Science. 2014 Jul 11;345(6193):216-20.
  • Fathi AT, Sadrzadeh H, Comander AH, Higgins MJ, Bardia A, Perry A, Burke M, Silver R, Matulis CR, Straley KS, Yen KE, Agresta S, Kim H, Schenkein DP, Borger DR.
    Isocitrate Dehydrogenase 1 (IDH1) Mutation in Breast Adenocarcinoma Is Associated With Elevated Levels of Serum and Urine 2-Hydroxyglutarate.
    Oncologist. 2014 Apr 23.
  • Reynolds K, Sarangi S, Bardia A, Dizon DS.
    Precision medicine and personalized breast cancer: combination pertuzumab therapy.
    Pharmgenomics Pers Med. 2014;7:95-105.
  • Bao T, Cai L, Snyder C, Betts K, Tarpinian K, Gould J, Jeter S, Medeiros M, Chumsri S, Bardia A, Tan M, Singh H, Tkaczuk KH, Stearns V.
    Patient-reported outcomes in women with breast cancer enrolled in a dual-center, double-blind, randomized controlled trial assessing the effect of acupuncture in reducing aromatase inhibitor-induced musculoskeletal symptoms.
    Cancer. 2014 Feb 1;120(3):381-9.
  • Carp SA, Sajjadi AY, Wanyo CM, Fang Q, Specht MC, Schapira L, Moy B, Bardia A, Boas DA, Isakoff SJ.
    Hemodynamic signature of breast cancer under fractional mammographic compression using a dynamic diffuse optical tomography system.
    Biomed Opt Express. 2013;4(12):2911-24.
  • Bardia A, Baselga J.
    Neoadjuvant therapy as a platform for drug development and approval in breast cancer.
    Clin Cancer Res. 2013 Dec 1;19(23):6360-70.
  • Ozkumur E, Shah AM, Ciciliano JC, Emmink BL, Miyamoto DT, Brachtel E, Yu M, Chen PI, Morgan B, Trautwein J, Kimura A, Sengupta S, Stott SL, Karabacak NM, Barber TA, Walsh JR, Smith K, Spuhler PS, Sullivan JP, Lee RJ, Ting DT, Luo X, Shaw AT, Bardia A, Sequist LV, Louis DN, Maheswaran S, Kapur R, Haber DA, Toner M.
    Inertial focusing for tumor antigen-dependent and -independent sorting of rare circulating tumor cells.
    Sci Transl Med. 2013 Apr 3;5(179):179ra47.
  • Yu M, Bardia A, Wittner BS, Stott SL, Smas ME, Ting DT, Isakoff SJ, Ciciliano JC, Wells MN, Shah AM, Concannon KF, Donaldson MC, Sequist LV, Brachtel E, Sgroi D, Baselga J, Ramaswamy S, Toner M, Haber DA, Maheswaran S.
    Circulating breast tumor cells exhibit dynamic changes in epithelial and mesenchymal composition.
    Science. 2013 Feb 1;339(6119):580-4.
  • Singla A, Kumar G, Bardia A.
    Personalizing cardiovascular disease prevention among breast cancer survivors.
    Curr. Opin. Cardiol. 2012 Sep;27(5):515-24.
  • Connolly RM, Bardia A.
    Trastuzumab for small HER-2+ breast cancer: small tumor, big decision.
    Oncologist. 2012;17(4):508-11.
  • Bardia A, Arieas ET, Zhang Z, Defilippis A, Tarpinian K, Jeter S, Nguyen A, Henry NL, Flockhart DA, Hayes DF, Hayden J, Storniolo AM, Armstrong DK, Davidson NE, Fetting J, Ouyang P, Wolff AC, Blumenthal RS, Ashen MD, Stearns V.
    Comparison of breast cancer recurrence risk and cardiovascular disease incidence risk among postmenopausal women with breast cancer.
    Breast Cancer Res Treat. 2012 Feb;131(3):907-14.
  • Jones JM, Qin R, Bardia A, Linquist B, Wolf S, Loprinzi CL.
    Antiemetics for chemotherapy-induced nausea and vomiting occurring despite prophylactic antiemetic therapy.
    J Palliat Med. 2011 Jul;14(7):810-4.
  • Gill S, Loprinzi C, Kennecke H, Grothey A, Nelson G, Woods R, Speers C, Alberts SR, Bardia A, O'Connell MJ, Sargent DJ.
    Prognostic web-based models for stage II and III colon cancer: A population and clinical trials-based validation of numeracy and adjuvant! online.
    Cancer. 2011 Mar 1.
  • Bardia A, Olson JE, Vachon CM, Lazovich D, Vierkant RA, Wang AH, Limburg PJ, Anderson KE, Cerhan JR.
    Effect of aspirin and other NSAIDs on postmenopausal breast cancer incidence by hormone receptor status: results from a prospective cohort study.
    Breast Cancer Res Treat. 2011 Feb;126(1):149-55.
  • Oxentenko AS, Bardia A, Vierkant RA, Wang AH, Anderson KE, Campbell PT, Sellers TA, Folsom AR, Cerhan JR, Limburg PJ.
    Body size and incident colorectal cancer: a prospective study of older women.
    Cancer Prev Res (Phila Pa). 2010 Dec;3(12):1608-20.
  • Bardia A, Stearns V.
    Personalized tamoxifen: a step closer but miles to go.
    Clin Cancer Res. 2010 Sep 1;16(17):4308-10.
  • Bardia A, Stearns V.
    Personal breast: customizing agents and biomarkers for optimal adjuvant endocrine therapy.
    Breast Cancer Res Treat. 2010 Apr;120(2):437-9.
  • Bardia A, Loprinzi C, Grothey A, Nelson G, Alberts S, Menon S, Thome S, Gill S, Sargent D.
    Adjuvant chemotherapy for resected stage II and III colon cancer: comparison of two widely used prognostic calculators.
    Semin Oncol. 2010 Feb;37(1):39-46.
  • Bardia A, Platz EA, Yegnasubramanian S, De Marzo AM, Nelson WG.
    Anti-inflammatory drugs, antioxidants, and prostate cancer prevention.
    Curr Opin Pharmacol. 2009 Aug;9(4):419-26. Review.
  • Bardia A, Novotny P, Sloan J, Barton D, Loprinzi C.
    Efficacy of nonestrogenic hot flash therapies among women stratified by breast cancer history and tamoxifen use: a pooled analysis.
  • Bardia A, Thompson S, Atherton PJ, Barton DL, Sloan JA, Kottschade LA, Christensen B, Collins M, Loprinzi CL.
    Pilot evaluation of aprepitant for the treatment of hot flashes.
    Support Cancer Ther. 2006 Jul 1;3(4):240-6.
  • Bardia A, Vachon CM, Olson JE, Vierkant RA, Wang AH, Hartmann LC, Sellers TA, Cerhan JR.
    Relative weight at age 12 and risk of postmenopausal breast cancer.
    Cancer Epidemiol Biomarkers Prev. 2008 Feb;17(2):374-8.
  • Bardia A, Tleyjeh IM, Cerhan JR, Sood AK, Limburg PJ, Erwin PJ, Montori VM.
    Efficacy of antioxidant supplementation in reducing primary cancer incidence and mortality: systematic review and meta-analysis.
    Mayo Clin Proc. 2008 Jan;83(1):23-34. Review.
  • Thompson S, Bardia A, Tan A, Barton DL, Kottschade L, Sloan JA, Christensen B, Smith D, Loprinzi CL.
    Levetiracetam for the treatment of hot flashes: a phase II study.
    Support Care Cancer. 2008 Jan;16(1):75-82.
  • Bardia A, Ebbert JO, Vierkant RA, Limburg PJ, Anderson K, Wang AH, Olson JE, Vachon CM, Cerhan JR.
    Association of aspirin and nonaspirin nonsteroidal anti-inflammatory drugs with cancer incidence and mortality.
    Journal of the National Cancer Institute. 2007 Jun 6;99(11):881-9.
  • Bardia A, Greeno E, Bauer BA.
    Dietary supplement usage by patients with cancer undergoing chemotherapy: does prognosis or cancer symptoms predict usage?.
    J Support Oncol. 2007 Apr;5(4):195-8.
  • Bardia A, Hartmann LC, Vachon CM, Vierkant RA, Wang AH, Olson JE, Sellers TA, Cerhan JR.
    Recreational physical activity and risk of postmenopausal breast cancer based on hormone receptor status.
    Arch Intern Med.;166(22):2478-83.
  • Bardia A, Barton DL, Prokop LJ, Bauer BA, Moynihan TJ.
    Efficacy of complementary and alternative medicine therapies in relieving cancer pain: a systematic review.
    J Clin Oncol. 2006 Dec 1;24(34):5457-64. Review.
  • Bardia A, Rao RD.
    Images in clinical medicine. Intratracheal melanoma metastases.
    N Engl J Med. 2006 Sep 28;355(13):1357.
  • Bardia A, Wahner-Roedler DL, Erwin PL, Sood A.
    Search strategies for retrieving complementary and alternative medicine clinical trials in oncology.
    Integr Cancer Ther. 2006 Sep;5(3):202-5.
  • Bardia A, Loprinzi CL, Goetz MP.
    Hand-foot syndrome after dose-dense adjuvant chemotherapy for breast cancer: a case series.
    J Clin Oncol. 2006 May 1;24(13):e18-9.
  • Bardia A, Pittelkow MR, Rao RD.
    Risk of multiple primary melanomas.
    JAMA. 2006 Apr 5;295(13):1516.